Home › Familial Amyloid Neuropathies › New York › New York City
Familial Amyloid Neuropathies clinical trials in New York City, NY
5 studies for Familial Amyloid Neuropathies are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
RecruitingObservational study
- Research Site, New York
- Research Site, New York
- Research Site, New York
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
RecruitingObservational study
- Clinical Trial Site, New York
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
RecruitingObservational study
- Columbia University Medical Center, New York
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- New York University (NYU) School of Medicine - Langone Medical Center, New York
- Mount Sinai Hospital, New York
- Columbia University Medical Center, New York
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
RecruitingObservational studyHealthy volunteers welcome
- Columbia University Irving Medical Center, New York
Familial Amyloid Neuropathies trials in other cities
- Boston, MA7 studies
- Dallas, TX4 studies
- Los Angeles, CA4 studies
- Cleveland, OH3 studies
- St. Louis, MO3 studies
- Rochester, MN3 studies
- San Diego, CA3 studies
- Durham, NC3 studies
- Philadelphia, PA3 studies
- Baltimore, MD3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.